Unia Europejska - polski - EMA (European Medicines Agency)

biogen idec ltd - daklizumab - stwardnienie rozsiane - leki immunosupresyjne - zinbryta jest wskazana u dorosłych pacjentów w leczeniu nawracających postaci stwardnienia rozsianego (rms).

Unia Europejska - polski - EMA (European Medicines Agency)

biogen netherlands b.v. - sól sodowa nusinersen - zanik mięśni, kręgosłup - inne leki na układ nerwowy - spinraza jest wskazany w leczeniu 5-rdzeniowego zaniku mięśni.

Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

cipla europe nv - natrii risedronas - tabletki powlekane - 35 mg

Unia Europejska - polski - EMA (European Medicines Agency)

regeneron ireland designated activity company (dac) - cemiplimab - rak, płaskonabłonkowy - Środki przeciwnowotworowe - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Unia Europejska - polski - EMA (European Medicines Agency)

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - Środki przeciwnowotworowe - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Unia Europejska - polski - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - okulistyka - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Unia Europejska - polski - EMA (European Medicines Agency)

biogen netherlands b.v. - diroximel fumarate (biib098) - stwardnienie rozsiane, Рецидивно-znika - leki immunosupresyjne - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Unia Europejska - polski - EMA (European Medicines Agency)

gedeon richter plc. - folitropina alfa - anovulation - hormony płciowe i modulatory układu rozrodczego, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. w badaniach klinicznych u tych pacjentów oceniali poziom endogennego lh w surowicy < 1. 2 iu / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

teva pharmaceuticals polska sp. z o.o. - natrii alendronas - tabletki - 70 mg

Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

ratiopharm gmbh - acidum alendronicum - tabletki - 70 mg